Darryl Nishimura is a prominent inventor based in Coralville, IA (US). He has made significant contributions to the field of genetics, particularly in relation to Bardet Biedl Syndrome (BBS). With a total of 8 patents to his name, Nishimura's work has the potential to impact diagnosis and therapy for genetic diseases.

Latest Patents

One of his latest patents is focused on the identification of a gene designated as negevin (ngvn), which is involved in Bardet Biedl Syndrome. This genetic condition is characterized by a range of symptoms, including obesity, diabetes, hypertension, mental retardation, renal cancer, retinopathy, and hypogonadism. The human NGVN protein is composed of 731 amino acids and is coded for by a gene that spans 17 exons. Homologs of this gene have been identified in various species, including mouse, rat, and zebrafish. The patent also describes methods of use for the gene, particularly in the diagnosis and therapy of BBS, as well as in drug screening.

Career Highlights

Darryl Nishimura is affiliated with the University of Iowa Research Foundation, where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to a better understanding of genetic disorders.

Collaborations

Some of his notable coworkers include Val C Sheffield and Edwin M Stone, who have collaborated with him on various research projects.

Conclusion

Darryl Nishimura's contributions to the field of genetics, particularly through his patents related to Bardet Biedl Syndrome, highlight his role as an influential inventor. His ongoing research at the University of Iowa Research Foundation continues to pave the way for advancements in genetic disease diagnosis and therapy.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]